ArticleBMC rheumatology2024

Nintedanib combined with immunosuppressive agents improves forced vital capacity in connective tissue disease-associated PF-ILD: a single-center study.

Yusuke Ushio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.